A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial–mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study

References

• PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
   PubMed Web of Science ®Google Scholar
• FeltisBNWignarajahDZhengLIncreased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthmaAm J Respir Crit Care Med2006173111201120716528018
   PubMed Web of Science ®Google Scholar
• SohalSSReidDSoltaniAReticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary diseaseRespirology201015693093820630030
   PubMed Web of Science ®Google Scholar
• SohalSSReidDSoltaniAEvaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary diseaseRespir Res20111213021970519
   PubMedGoogle Scholar
• SohalSSWaltersEHEpithelial mesenchymal transition (EMT) in small airways of COPD patientsThorax201368878378423492370
   PubMed Web of Science ®Google Scholar
• SohalSSWaltersEHRole of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)Respir Res20131412024195704
   PubMed Web of Science ®Google Scholar
• SohalSSWardCDanialWWood-BakerRWaltersEHRecent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary diseaseExpert Rev Respir Med20137327528823734649
   PubMed Web of Science ®Google Scholar
• SohalSSSoltaniAWestonSWood-BakerRWaltersEHIntermediate filament vimentin and potential role in epithelial mesenchymal transition (EMT)De MelloRAVimentin Concepts and Molecular MechanismsNew YorkNova Publishers20133761
   Google Scholar
• SoltaniAMullerHKSohalSSDistinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same diseaseHistopathology201260696497022320998
   PubMed Web of Science ®Google Scholar
• ZeisbergMNeilsonEGBiomarkers for epithelial-mesenchymal transitionsJ Clin Invest200911961429143719487819
   PubMed Web of Science ®Google Scholar
• KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest200911961420142819487818
   PubMed Web of Science ®Google Scholar
• SoltaniAReidDWSohalSSBasement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional studyRespir Res20101110520670454
   PubMed Web of Science ®Google Scholar
• KalluriRNeilsonEGEpithelial-mesenchymal transition and its implications for fibrosisJ Clin Invest2003112121776178414679171
   PubMed Web of Science ®Google Scholar
• YoungRHopkinsREtzelCEl-ZeinRGenetics of lung cancer susceptibility and COPDLancet Oncol201112762262321708349
   PubMed Web of Science ®Google Scholar
• GarberKEpithelial-to-mesenchymal transition is important to metastasis, but questions remainJ Natl Cancer Inst2008100423223323918270330
   PubMedGoogle Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
   PubMed Web of Science ®Google Scholar
• ReidDWWenYJohnsDPWilliamsTJWardCWaltersEHBronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not relatedRespirology200813679980918811878
   PubMed Web of Science ®Google Scholar
• ParimonTChienJWBrysonCLMcDonellMBUdrisEMAuDHInhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175771271917185647
   PubMed Web of Science ®Google Scholar
• KiriVAFabbriLMDavisKJSorianoJBInhaled corticosteroids and risk of lung cancer among COPD patients who quit smokingRespir Med20091031859018793832
   PubMed Web of Science ®Google Scholar
• ArainMCampbellMJCooperCLLancasterGAWhat is a pilot or feasibility study? A review of current practice and editorial policyBMC Med Res Methodol2010106720637084
   PubMed Web of Science ®Google Scholar
• LancasterGADoddSWilliamsonPRDesign and analysis of pilot studies: recommendations for good practiceJ Eval Clin Pract200410230731215189396
   PubMed Web of Science ®Google Scholar
• SohalSSReidDSoltaniAChanges in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trialPLoS One201385e6483323717666
   PubMed Web of Science ®Google Scholar
• RichmondIBoothHWardCWaltersEHIntrasubject variability in airway inflammation in biopsies in mild to moderate stable asthmaAm J Respir Crit Care Med199615338999038630570
   PubMed Web of Science ®Google Scholar
• LuepkerRVRaczynskiJMOsganianSEffect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) TrialJAMA20002841606710872014
   PubMed Web of Science ®Google Scholar
• WardCForrestIAMurphyDMPhenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipientsThorax2005601086587115972366
   PubMed Web of Science ®Google Scholar
• KalluriREMT: when epithelial cells decide to become mesenchymal-like cellsJ Clin Invest200911961417141919487817
   PubMed Web of Science ®Google Scholar
• MilaraJPeiroTSerranoACortijoJEpithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smokeThorax201368541042023299965
   PubMed Web of Science ®Google Scholar
• WangQWangYZhangYZhangYXiaoWThe role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary diseaseRespir Res2013146723806081
   PubMed Web of Science ®Google Scholar
• DasariVGallupMLemjabbarHMaltsevaIMcNamaraNEpithelial-mesenchymal transition in lung cancer: is tobacco the “ smoking gun”?Am J Respir Cell Mol Biol20063513916484682
   PubMed Web of Science ®Google Scholar
• BarnesPJAdcockIMChronic obstructive pulmonary disease and lung cancer: a lethal associationAm J Respir Crit Care Med2011184886686722003145
   PubMed Web of Science ®Google Scholar
• YangIARelanVWrightCMCommon pathogenic mechanisms and pathways in the development of COPD and lung cancerExpert Opin Ther Targets201115443945621284573
   PubMed Web of Science ®Google Scholar
• HattotuwaKLGizyckiMJAnsariTWJefferyPKBarnesNCThe effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy studyAm J Respir Crit Care Med2002165121592159612070058
   PubMed Web of Science ®Google Scholar
• ChanezPBourdinAVachierIGodardPBousquetJVignolaAMEffects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary diseaseProc Am Thorac Soc20041318419016113433
   PubMedGoogle Scholar
• GreenbergAKHuJBasuSGlucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulatorsAm J Respir Cell Mol Biol200227332032812204894
   PubMed Web of Science ®Google Scholar
• YaoRWangYLemonWJLubetRAYouMBudesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressionsOncogene200423467746775215361829
   PubMed Web of Science ®Google Scholar
• WattenbergLWWiedmannTSEstensenRDZimmermanCLSteeleVEKelloffGJChemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J miceCancer Res19975724548954929407956
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• MillerYEKeithRLInhaled corticosteroids and lung cancer chemopreventionAm J Respir Crit Care Med2007175763663717384324
   PubMed Web of Science ®Google Scholar
• van GestelYRHoeksSESinDDCOPD and cancer mortality: the influence of statinsThorax2009641196396719720607
   PubMed Web of Science ®Google Scholar